After graduating with his MBBS medical degree from the University of Bombay in Mumbai, India, he completed his Internal Medicine residency in Mumbai. He also completed an internship at LaGuardia Hospital (now Long Island Jewish Forest Hills), as well as his Hematology/Oncology residency and Bone Marrow Transplantation Fellowship at Wayne State University. Following his fellowship, Dr. Gadgeel served as director of the Thoracic Oncology Program and co-leader of Molecular Therapeutics Program at Karmanos Cancer Institute/Wayne State University.

Prior to Henry Ford, Dr. Gadgeel was a professor in the Department of Internal Medicine and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan/Michigan Medicine.

Dr. Gadgeel enhances our academic mission through clinical trials and research, while promoting the growth and expansion of clinical services locally, regionally, and nationally -- further positioning Henry Ford Cancer Institute as a destination and referral center for cancer care. He is the principle investigator on numerous clinical trials, and has published extensively in peer-reviewed literature.

His clinical research experience spans over 20 years. He has more than 200 peer reviewed publications as well as he has authored several book chapters and has been invited to speak at several oncology meetings around the world. He is also a member of the steering committee of the Lung Cancer Committee of Southwest Oncology Group. He is the Associate Editor of Clinical Lung Cancer and a reviewer for many journals, including Clinical Cancer Research, Journal of Clinical Oncology, Lancet Oncology, and Journal of Thoracic Oncology. He has served as faculty for the annual meeting of the American Society of Clinical Oncology (ASCO) and as a member of the education committee of ASCO. He is a member of the Communications committee of the International Association of Study of Lung Cancer (IASLC). He was awarded by the National Cancer Institute the Cancer Clinical Investigator Team Leadership Award in 2012.

After graduating with his MBBS medical degree from the University of Bombay in Mumbai, India, he completed his Internal Medicine residency in Mumbai. He also completed an internship at LaGuardia Hospital (now Long Island Jewish Forest Hills), as well as his Hematology/Oncology residency and Bone Marrow Transplantation Fellowship at Wayne State University. Following his fellowship, Dr. Gadgeel served as director of the Thoracic Oncology Program and co-leader of Molecular Therapeutics Program at Karmanos Cancer Institute.

Prior to Henry Ford, Dr. Gadgeel was a professor in the Department of Internal Medicine and the Mary Lou Kennedy Research Professor in Thoracic Oncology at the University of Michigan/Michigan Medicine.

Dr. Gadgeel enhances our academic mission through clinical trials and research, while promoting the growth and expansion of clinical services locally, regionally, and nationally -- further positioning Henry Ford Cancer Institute as a destination and referral center for cancer care. He is the principle investigator on numerous clinical trials, and has published extensively in peer-reviewed literature.

His clinical research experience spans 20 years. He is also a member of the steering committee of the Lung Cancer Committee of Southwest Oncology Group. He is the Associate Editor of Clinical Lung Cancer and a reviewer for many journals, including Clinical Cancer Research, Journal of Clinical Oncology, Lancet Oncology, and Journal of Thoracic Oncology. He has served as faculty for the annual meeting of the American Society of Clinical Oncology (ASCO) and as a member of the education committee of ASCO. He is a member of the Communications committee of the International Association of Study of Lung Cancer (IASLC). He was awarded by the National Cancer Institute the Cancer Clinical Investigator Team Leadership Award in 2012.